Colorectal cancer screening in kidney disease patients: Working backwards

Nephrology Dialysis Transplantation

Volumn 28, Issue 4, 2013, Pages 774-777

  Kiberd, Bryce ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

cancer screening; dialysis; end stage renal disease; kidney transplantation; outcomes

Indexed keywords

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CHRONIC KIDNEY DISEASE; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEALTH CARE QUALITY; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; KIDNEY CANCER; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; OCCULT BLOOD TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SIGMOIDOSCOPY; UTERINE CERVIX CANCER;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MASS SCREENING; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84876003655     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs523     Document Type: Article

References (27)

1. Schwartz LM, Woloshin S, Fowler FJ, Jr et al. Enthusiasm for cancer screening in the United States. JAMA 2004; 291: 71-78 (Pubitemid 38040537)
2. Woolf SH, Harris R. The harms of screening: new attention to an old concern. JAMA 2012; 307: 565-566
3. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003; 289: 1414-1420 (Pubitemid 37430309)
4. Heijnsdijk EAM, Wever EM, Auvinen A et al. Quality-of-life effects of prostate-specific antigen screening. N Engl J Med 2012; 367: 595-605
5. Hofer TP, Hayward RA. Are Bad outcomes from questionable clinical decisions preventable medical errors? A case of cascade iatrogenesis. Ann Intern Med 2002; 137(5 Part 1): 327-333 (Pubitemid 34977134)
6. US Renal Data System. USRDS 2000 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000
7. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2008; 149: 627-637
8. Screening for colorectal cancer: a guidance statement fromtheAmerican College of Physicians. Ann Intern Med 2012; 156: 378-386
9. US Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
10. Engels EA, Pfeiffer RM, Fraumeni JF et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891-1901
11. Kasiske BL, Snyder JJ, Gilbertson DT et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-913 (Pubitemid 38745589)
12. Webster AC, Craig JC, Simpson JM et al. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. Am J Transplant 2007; 7: 2140-2151 (Pubitemid 47247055)
13. Wong G, Li MWY, Howard K et al. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Nephrol Dial Transplant 2013; 28: 917-926
14. Wong G, Howard K, Craig JC et al. Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation 2008; 85: 532-541
15. Wong G, Howard K, Webster AC et al. Screening for renal cancer in recipients of kidney transplants. Nephrol Dial Transplant 2011; 26: 1729-1739
16. Wong G, Howard K, Webster A et al. The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients. Transplantation 2009; 87: 1078-1091
17. Wong G, Howard K, Chapman JR et al. Cost-effectiveness of breast cancer screening in women on dialysis. Am J Kidney Diseases 2008; 52: 916-929
18. Robinson BM, Port FK. International hemodialysis patient outcomes comparisons revisited: the role of practice patterns and other factors. Clin J Am Soc Nephrol 2009;4: S12-S17
19. Kiberd BA, Keough-Ryan T, Clase CM. Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant 2003; 3: 619-625 (Pubitemid 36612846)
20. Frazier AL, Colditz GA, Fuchs CS et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284: 1954-1961
21. Wong G, Howard K, Chapman J et al. Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol. BMC Public Health 2011; 11: 516
22. Collins MG, Teo E, Cole SR et al. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy. BMJ 2012; 345: e4657
23. Schoen RE, Pinsky PF, Weissfeld JL et al.; PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366: 2345-2357
24. Inadomi JM, Vijan S, Janz NK et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 2012; 172: 575-582
25. Walter LC, Davidowitz NP, Heineken PA et al. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA 2004; 291: 2466-2470 (Pubitemid 38669190)
26. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 2750-2756 (Pubitemid 32525372)
27. Choosing Wisely. Retrieved from Internet on 11 August 2012. http://www.abimfoundation.org/News/ABIM-Foundation-News/2012/Choosing-Wisely. aspx